Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,601–2,700 of 2,883
Alcaraz, M., Ramachandra, R., Arnold, R., Teneche, M. G., Rajesh, A., Haddadin, L., Taing, M., Lei, X., Gandhi, A., Tzaridis, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743365 · Cited by 1
Metabolic disorders, obesity, and accelerated cardiac senescence
Sultana, A., Sulthana, N., Roja, P., Rana, A. J., Hussain, M. S., & Boddupalli, B. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45811-8.00017-9
Coronado, R. E. (2026) · GeroScience · doi:10.1007/s11357-026-02554-8
Schmitt, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00006-7
Zhang, Q., Hu, D., Lin, Z., & Jiang, J. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf546
“CDKN2A encodes two crucial cell cycle regulators, p16 and p14, which are involved in cell cycle progression [27], differentiation [28], senescence [29], and apoptosis [30].”
Generation of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Zhang, L., Jiang, Y., Zheng, Y., Lu, H., Lin, Z., Wang, Y., Zhu, C., Ding, S., Li, C., Zhou, G., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120809
Cellular senescence: six decades of discovery and reinvention
Klaver, M., Steeneken, L. S., Veeningen, N., Altulea, A., & Demaria, M. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00922-w
Bisht, S., Varshney, P., & Gupta, A. (2026) · Targets · doi:10.3390/targets4020012 · Cited by 1
NIH SenNet Consortium: Mapping Senescent Cells in the Human Body to Understand Health and DiseasePreprint
Lee, P. J., Blood, P. D., Börner, K., Campisi, J., Chen, F., Daldrup-Link, H. E., Jager, P. L. D., Ding, L., Duncan, F. E., Eickelberg, O., et al. (2022) · Preprints.org · doi:10.20944/preprints202207.0160.v2 · Cited by 1
Cellular senescence as a quality parameter in chronological aging
Rodea, S., & Eduvigis Solórzano, N. (2023) · Acta Bioclínica · doi:10.53766/acbio/2023.13.26.13
She, J., & Wang, C.-Y. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733607913.793549270
Guo, J.-Q., Wang, Q., Zhang, Y.-M., Li, J., Yang, L., Zhang, X., Han, M.-M., Xi, H., Qi, R., & Cai, J. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.031
p16 INK4A expression induces paracrine senescence via small extracellular vesiclesPreprint
Menendez-Garcia, M., Merino-Navarro, A., & O’Loghlen, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.09.689258
Steroid hormone receptors in aging and neurodegenerative diseases
Kumar, R., & McEwan, I. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91141-2.00001-5
Liu, Z., Abulaiti, A., Li, D., Li, J., Wahafu, P., Zhang, Y., Maimaitiming, M., Li, S. Y., Li, G., & Yakufu, M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103221 · Cited by 1
Senescent cell accumulation & Research-based undergraduate education
Valentijn, F. A. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1121
Senescent Cells and Antiaging Medicine: Selective Removal of Senescent Cells
Nakagami, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-8514-8_27
Birth and death of cellular senescence
Wang, B. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.131223530
Cellular senescence during aging
von Zglinicki, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00017-3 · Cited by 1
Ablation of Arf -expressing cells ameliorates cigarette smoke-induced lung dysfunction in micePreprint
Mikawa, R., Sato, T., Suzuki, Y., Baskoro, H., & Sugimoto, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/809160
Epigenetic Iinsights into the Senescence of Porcine Fetal Fibroblasts induced by Passaging
Bi, J., Wang, D., Zhu, F., Lu, X., Xie, Y., Liu, H., Wang, M., He, X., Jiang, Y. Z., Liu, P., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2222521
“Furthermore, cell senescence and metabolism are intricately linked, and cell senescence often accompanied by permanent cell proliferation arrest and multiple phenotypic changes [48] could alter lipid metabolism [49] and promote metabolic dysfunction [50] and metabolic disease [51,52].”
BackgroundIshaq, A., & Saretzki, G. C. (2022) · Recent Progress in Nutrition · doi:10.21926/rpn.2203016
Volonté, D., Mullett, S. J., Gelhaus, S. L., & Galbiati, F. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113094
“Elimination of senescent cells, either genetically (30, 31) or through the use of senolytics (32–34), delays age-linked phenotypes and cancer-associated death in vivo .”
The vicious cycle of SASP and inflammaging promotes aging and age-related diseases
Liu, Q., Zheng, Y., & Sun, C. (2026) · Communications Biology · doi:10.1038/s42003-026-10826-4 · Cited by 1
Accelerated Lung Aging and Cellular Senescence in COPD
Barnes, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00058-5
Lu, Y., Zhang, C., Wu, B., Guo, J., Fan, D., Wang, G., Zhang, W., Lin, L., Xu, X., Du, X., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137914
Zhang, M., & Xuan, Z. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735010803.793558596
Bashir, S., Wilson, M., Ashiru-Oredope, D. A. I., & Murdan, S. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-35811-1_9
Characterization and impact of cellular senescence during mammary gland involution
Charifou, E. (2022) · theses.fr (ABES) · doi:10.70675/54491057z33e4z449fzb26fz6a2e42b1a22e
Cellular senescence and other aging mechanisms in bone and muscle
Kaur, J., & Farr, J. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00008-1
The quest to turn back the clock
Bhambra, R. (2023) · Biopharma Dealmakers · doi:10.1038/d43747-023-00126-9
Muehlich, S., & Mittermeier, C. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727857070.793537467
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
Sun, L., Zhang, Y., Zhang, H., Liu, H., Xu, J., Liu, J., Liu, C., Peng, J., & Liu, X. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.07.026
Li, F., Wang, Y., Wang, G., Chen, J., & Huang, S. (2026) · Aging Cell · doi:10.1111/acel.70658
“In 2011, Baker et al. showed that eliminating p16 INK4a - positive senescent cells delayed age-associated phenotypes and extended both lifespan and healthspan in mice (Baker et al. 2011; Baker et al. 2016).”
Wu, L., Chua, Z. X., Wang, M., et al. (2026) · Journal of Regenerative Medicine and Biology Research · doi:10.46889/jrmbr.2026.7304
“Reversibly targeting these senescent cell populations restores adipocyte functionality and extends healthspan in animal models; 3) The skin Extracellular Matrix (ECM), which is composed of collagen and Hyaluronic Acid (HA), plays a critical role in cutaneous aging [20].”
Tubular Physiology in Acute Kidney Injury: Cell Signalling, Injury and Inflammation
Ferenbach, D. A., O'Sullivan, E. D., & Bonventre, J. V. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8628-6_5
Lin, J. (2024) · Research in Health Science · doi:10.22158/rhs.v9n3p128
Stage-dependent transcriptomic changes in human dermal fibroblast senescence model
Kudo, M., Yonezawa, R., Mizobata, H., Kinoshita, S., & Asakawa, S. (2026) · Aging · doi:10.18632/aging.206371 · Cited by 1
“AGING Senescent cells accumulate in various tissues with age [12 – 15] and may adversely affect the surrounding tissue environment by secreting factors such as inflammatory cytokines (SASP), thereby promoting age-related diseases and organismal aging [16, 17].”
Cellular senescence and senolytic therapy in traumatic brain injury
Brann, D. W., Singh, H. D., Wang, J., Lu, Y., Carr, C., & Dhandapani, K. M. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1862748
Clearance of p16‐positive cardiac cells improves age‐related cardiac remodeling in mice
Mehdizadeh, M., Mackasey, M., Gharagozloo, K., Aguilar, M., Naud, P., Ochs, A., Vuong, N., Thorin, É., Ferbeyre, G., Tardif, J., et al. (2026) · Experimental Physiology · doi:10.1113/ep093551 · Cited by 1
“Baker et al. showed that the clearance of p16-positive senescent cells in aged mice reduces cardiomyocyte size (Baker et al., 2016).”
InfluentialInvestigating senescence in cellular plasticity and tissue regeneration
Ritschka, B. (2017) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Jiang, Z., Baechler, B. L., Li, H., Lad, H., Ciavarra, G., Ben‐David, Y., Burden, S. J., Quadrilatero, J., & Zacksenhaus, E. (2025) · Oncogene · doi:10.1038/s41388-025-03487-w
Faculty Opinions recommendation of Fisetin is a senotherapeutic that extends health and lifespan.
Schumacher, B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734139615.793563345
The role of Activin signaling pathway in the initiation and progression of pancreatic cancer
Zhao, Y. (2019) · theses.fr (ABES) · doi:10.70675/17612dbdz6d94z4563z86a3z6d1e91b34f9b
Sewell, P. E. (2026) · Aging · doi:10.18632/aging.206416
“Unlike p53-mediated senescence, p16-mediated arrest is considered largely irreversible under physiological conditions [48, 49].”
Senescence targeting re-enables injury-responsive repair in a human RPE aging modelPreprint
Ritschka, B., Etl, C., Perez, F. B., Ishihara, K., Almedawar, S., Leyva‐González, M. A., Neubauer, H., Bakker, R. A., & Tanaka, E. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.722664
“Senescent cells contribute to tissue dysfunction and impaired repair during aging and age-related diseases 40,41 , and senolytic strategies have emerged as potential therapeutic approaches 42,43 .”
The role of senescence in kidney ageing, injury and fibrosis
Janas, P. P., Mason, T., & Ferenbach, D. A. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01123-8
Biology of Telomeres and Telomerase in Ageing
Saretzki, G. C. (2026) · Wiley eBooks · doi:10.1002/9780470015902.a0029951
Non-canonical cell death by reassortant reovirusPreprint
Stewart, R. M. R., Raghuram, V., Berry, J. T. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.107706
Jiang, Q., & Yan-Jiang, W. A. N. G. (2026) · Shengming kexue · doi:10.3724/cbls.2026100
Percolation based tissue modeling
Stehlík, M., Kiseľák, J., & Londoño, D. L. (2018) · AIP conference proceedings · doi:10.1063/1.5064878
Identifying key targets and immune environment in wound healing based on iron overload-related genes
Peng, Y., Sheng, J., Liu, T., He, R., & Xu, P. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04140-y
“Furthermore, via regulating HIF1A gene expression, PDK4 enhances fibroblast activity and diabetic WH [27]. p16, commonly referred to as cyclin dependent kinase inhibitor 2A (CDKN2A), is essential for controlling the cell cycle and proliferation of cells [28–30].”
Rôle de l’immunosurveillance des cellules sénescentes dans le cancer et le vieillissement
Iltis, C. (2020) · theses.fr (ABES) · doi:10.70675/9a339b58z5fecz427dz8de4z8ce0bd748478 · Cited by 1
Immunotherapy and Senolytics: Alleviating radiation-induced senescence
Veltman, H. (2021)
Single‐Cell Transcriptomic Landscape of Smoking‐Related Periodontitis
Wang, H., Hu, P., Wu, J., Huang, R., Jw, M., Zhang, X., Yi, M., Tu, J., Jia, R., Zhao, S., et al. (2026) · Oral Diseases · doi:10.1111/odi.70392
uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome
Hayek, S. S., & Dryer, S. E. (2026) · Circulation Research · doi:10.1161/circresaha.126.328563 · Cited by 1
“140,141 uPAR surface expression increases across multiple senescence triggers, and engineered CAR (chimeric antigen receptor) T cells directed against uPAR selectively ablate senescent cells in vitro and in vivo.”
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Paltsyn, A. A. (2019) · Nauchno-prakticheskii zhurnal «Patogenez» · doi:10.25557/2310-0435.2019.04.78-84
He, J., Li, X., Wang, J., Guo, X., Wang, S., Chu, H. X., Xu, H., & Wang, Y. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70744
Topisirović, I. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727678532.793561694
RPE Senescence and Its Implication in Age-Related Macular Degeneration
Wang, S., Zhou, Q., & Tong, Y. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_6
Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés
Maggiorani, D. (2017) · theses.fr (ABES) · doi:10.70675/a58747bczd60bz4482za3b2z7ae33d26ffa4 · Cited by 1
Senolytic drug discovery and mechanisms of action in BRAF-V600E oncogene-induced senescence
L’Hôte, V. (2022) · theses.fr (ABES) · doi:10.70675/acd5f426zc1b2z446fz8404z0f8f121081f8 · Cited by 1
Subtelomere-Telomere Aging Theory
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_5
Gold, M. R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734674689.793558446
Hernández‐Camacho, J. D., & Saclier, M. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70212
“The removal of p16 + cells in the INK‐ATTAC non progeroid mouse extends healthy lifespan without improving physical condition suggesting another contributor in addition to p16 + cells to muscle ageing (Baker et al. 2016).”
Timing‐Dependent Clearance of p16‐Positive Cells Mitigates Radiation‐Induced Accelerated Aging
Valdivieso, K., Weigand, M., Costa, D. G., Lee, G., Pirius, N., Martini, H., Oberai, S., Inman, C., Zhu, Y. Z., von Zglinicki, T., et al. (2026) · Aging Cell · doi:10.1111/acel.70693
“Senescent cells have emerged as key contributors to aging and age-related disease (Baker et al. 2016; Ogrodnik et al. 2017; Ogrodnik et al. 2019).”
Majeed, Y., Halabi, N. M., Engelke, R., Sarwath, H., Al-Noubi, M. N., Choi, S., Al-Malki, A., Agha, M. V., Vakayil, M., Chouchane, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.20.660826
Dissecting out the unexpected effects of SGLT2 inhibitors on human aging
Katsuumi, G., & Minamino, T. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag207 · Cited by 1
Jurdi, N. E., Elhusseini, H., Cao, Q., Klinger, T. S., Shapiro, E., Cömert, M., Juckett, M. B., Holtan, S. G., & Yousefzadeh, M. J. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1673230
Wang, G., Meng, Y., & Han, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103293
Dissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Role of Altered Extracellular Signalling in Cellular Senescence
Takasugi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11427-8
Li, B., Xiang, W., Qi, W., Liu, X., Zhu, W., Zhang, W., Jin, R., Ma, S., Chen, L., Bai, C., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108461
Schäffer, A. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732136102.793542774
Senescence of vascular endothelial cell
Suda, M., Shimizu, I., & Minamino, T. (2019) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.30.521
Melk, A., & Erlangga, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00015-8
Renal aging and associated diseases: Common mechanisms and therapeutic approaches
Muhammad, J. A., Julianto, N. M., Setiawan, T., Fadjaray, T. F., Elbert, F., Hussain, M., Wirawan, L. M., Jeong, D., & Kwon, H. Y. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100148 · Cited by 1
Destroying worn-out cells makes mice live longer
Callaway, E. (2016) · Nature · doi:10.1038/nature.2016.19287
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.